General recommendation: Studies in rabbits have shown reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions). The effect of teriparatide on human foetal development has not been studied. The potential risk for humans is unknown.
It is not known whether teriparatide is excreted in human milk.
FORTEO is contraindicated for use during pregnancy or breast-feeding.
Women of childbearing potential/Contraception in females: Women of childbearing potential should use effective methods of contraception during use of FORTEO. If pregnancy occurs, FORTEO should be discontinued.